ABSTRACT
This study aimed to evaluate the therapeutic effect of IR-61, a novel mitochondrial heptamethine cyanine dye with antioxidant effects, on diabetes mellitus-induced erectile dysfunction (DMED). Eight-week-old male Sprague-Dawley rats were intraperitoneally injected with streptozotocin (STZ) to induce type 1 diabetes. Eight weeks after STZ injection, all rats were divided into three groups: the control group, DM group, and DM + IR-61 group. In the DM + IR-61 group, the rats were administered IR-61 (1.6 mg kg-1) twice a week by intravenous injection. At week 13, erectile function was evaluated by determining the ratio of the maximal intracavernous pressure to mean arterial pressure, and the penises were then harvested for fluorescent imaging, transmission electron microscopy, histological examinations, and Western blot analysis. Whole-body imaging suggested that IR-61 was highly accumulated in the penis after intravenous injection. IR-61 treatment significantly improved the maximal ICP of diabetic rats. Additionally, IR-61 ameliorated diabetes-induced inflammation, apoptosis, and phenotypic transition of corpus cavernosum smooth muscle cells (CCSMCs) in penile tissue. IR-61 also attenuated mitochondrial damage, reduced reactive oxygen species production in the corpus cavernosum and upregulated sirtuin1 (SIRT1), sirtuin3 (SIRT3), nuclear factor (erythroid-derived 2)-like 2 (Nrf2), and heme oxygenase expression in penile tissue. In conclusion, IR-61 represents a potential therapeutic option for DMED by protecting the mitochondria of CCSMCs, which may be mediated by activation of the SIRT1, SIRT3, and Nrf2 pathways.
Subject(s)
Carbocyanines/pharmacology , Diabetes Mellitus, Experimental/complications , Erectile Dysfunction/drug therapy , Erectile Dysfunction/etiology , Animals , Antioxidants/pharmacology , Antioxidants/therapeutic use , Diabetes Mellitus, Experimental/drug therapy , Disease Models, Animal , Male , Rats , Rats, Sprague-DawleyABSTRACT
High intensity focused ultrasound (HIFU) technology is becoming a potential noninvasive treatment for solid tumor. To explore whether HIFU can be applied to treat melanoma and its metastasis, we investigated the effect of HIFU on murine melanoma model. While there was little influence on cell survival, viability or apoptosis, HIFU exposure suppressed melanoma cell migration in vitro and metastasis in vivo. The expression of microRNA-21(miR-21) was down-regulated and PTEN expression was up-regulated in response to HIFU exposure, which was in concomitant with the reduction of AKT activity. Furthermore, ectopic miR-21 expression suppressed this effect of HIFU. These results demonstrate that HIFU exposure can inhibit AKT-mediated melanoma metastasis via miR-21 inhibition to restore PTEN expression. Therefore, targeting the miR-21/PTEN/AKT pathway might be a novel strategy of HIFU in treatment of melanoma.
Subject(s)
Melanoma, Experimental/metabolism , Melanoma, Experimental/therapy , MicroRNAs/metabolism , PTEN Phosphohydrolase/metabolism , Skin Neoplasms/metabolism , Skin Neoplasms/therapy , Ultrasonic Therapy/methods , Animals , Apoptosis , Cell Movement , Cell Survival , Down-Regulation , Female , Mice , Mice, Inbred C57BL , Neoplasm Metastasis , Neoplasm Transplantation , Up-RegulationABSTRACT
HIFU has been demonstrated to enhance anti-tumor immunity, however, the mechanism of which has not been well elucidated. Emerging evidence indicates that miRNAs play important roles in immune response. In this study, we used the B16F10 melanoma allograft mouse model to investigate the role of miRNAs in HIFU-enhanced anti-tumor immunity. We found that HIFU treatment decreased circulating B16F10 cells and pulmonary metastasis nodules while increased IFN-γ and TNF-α in the peripheral blood and cumulative mouse survival, which was associated with inhibition of miR-134 expression and activation of CD86 expression in tumor tissues. Further, we determined that miR-134 directly binds to the 3'UTR of CD86 mRNA to suppress its expression in B16F10 cells. When B16F10 cells transfected with miR-134 were co-cultured with normal splenic lymphocytes, the secretion of IFN-γ and TNF-α from lymphocytes was reduced and B16F10 cell survival was increased. HIFU exposure efficiently decreased miR-134 while increased CD86 expression in B16F10 cells in vitro. CD86 knockdown with siRNA markedly rescued the viability of HIFU-treated B16F10 cells that co-cultured with lymphocytes. Altogether, our results suggest that HIFU down-regulates miR-134 to release the inhibition of miR-134 on CD86 in melanoma cells, thereby enhancing anti-tumor immune response.
Subject(s)
B7-2 Antigen/antagonists & inhibitors , Lung Neoplasms/immunology , Melanoma, Experimental/immunology , MicroRNAs/genetics , Ultrasonic Therapy , Animals , Apoptosis/genetics , Apoptosis/radiation effects , B7-2 Antigen/genetics , B7-2 Antigen/metabolism , Blotting, Western , Cell Proliferation/genetics , Cell Proliferation/radiation effects , Female , Flow Cytometry , Humans , Lung Neoplasms/diagnostic imaging , Lung Neoplasms/genetics , Lung Neoplasms/secondary , Melanoma, Experimental/diagnostic imaging , Melanoma, Experimental/genetics , Melanoma, Experimental/pathology , Mice , Mice, Inbred C57BL , RNA, Messenger/genetics , Real-Time Polymerase Chain Reaction , Reverse Transcriptase Polymerase Chain Reaction , Tumor Cells, Cultured , Ultrasonography , Xenograft Model Antitumor AssaysABSTRACT
BACKGROUND: There is a growing interest in studying the relationship between intrinsic resistance and biofilms resistance to drugs. However, the relationship still remains unclear in the macroscopic bacterial growth. Our study is to illuminate the change of bacterial drug resistance of gyrA mutant and active efflux pump during the development of Pseudomonas aeruginosa (P. aeruginosa) biofilms. METHODS: The strains of type II topoisomerase gene mutant (gyrA mutant) and multidrug resistance (MDR) efflux pump were clinical isolates and detected by polymerase chain reaction (PCR). The process of bacterial biofilms development was observed by scanning electron microscope. Triparental mating experiments were performed to transfer report gene of green fluorescent protein (GFP) into P. aeruginosa biofilms strains and followed by analysis of bacterial survival rate between intrinsic resistance and biofilms resistance. RESULTS: The fluorescent strains with pGFPuv could develop mature biofilms on Teflon surface. Before a period of 72 hours, the survival rate of biofilms bacteria and intrinsic resistance strains in ciprofloxacin solution was significantly different (P < 0.05). The survival number of intrinsic resistance strains (gyrA mutation and active efflux pump) was illustriously higher than biofilm strain in the initial stage of biofilms development. After 72 hours incubation, there was no clearly difference between mutants and biofilms strains in the survival rate (P > 0.05). The carbonyl cyanide m-chlorophenylhydrazone and azithromycin could significantly reduce the drug resistance of biofilm strains and efflux pump strains. CONCLUSIONS: In the development of P. aeruginosa biofilms, the strains of gyrA mutation and MDR efflux could be conferred with new level of drug resistance. When co-cultured mutated strains with biofilm strains, biofilms may play a major role in bacterial resistance. But after 72 hours incubation (a mature biofilms had been developed), there was no clearly difference between the number of mutant strains and biofilm strains.
Subject(s)
Biofilms/drug effects , Pseudomonas aeruginosa/drug effects , Carbonyl Cyanide m-Chlorophenyl Hydrazone/pharmacology , Ciprofloxacin/pharmacology , DNA Gyrase/genetics , Drug Resistance, Bacterial , Mutation , Pseudomonas aeruginosa/geneticsABSTRACT
OBJECTIVE: This work was directed at obtaining a better gene carrier to improve the effects of gene delivery. METHODS: Cationic liposomes made from cholesterol, lecithin and Eighteenth Amic by reverse evaporation technique were used for encapsulating plasmid DNA containing gfp gene. The DNA/liposome complexes differed in quantity of plasmid DNA. The sizes of complexes and the efficiency of encapsulation were detected. MTT assay was used to measure the cytotoxicities of complexes. The efficiency of transfection into COS1 cells was shown by observation of green fluorescent and measurement of fluorescent intensity. RESULTS: The average size of complexes was 562 nm, the encapsulating efficiency of DNA in microspheres reached 55%-65%. These DNA/Cationic liposome complexes could be transfected into mammalian cells, but they were different from each other in efficiency of transfection. The cytotoxicities of these complexes varied with the concentration of DNA in complexes, the quantities of complexes and the time of treatment by complexes. CONCLUSION: DNA/Cationic liposome complexes prepared by reverse evaporation technique could be applied in DNA delivery system.